Hematologic Oncology | Specialty

The OncLive Hematology Oncology condition center page is a comprehensive resource for clinical news and expert insights on various hematologic malignancies, including leukemias, lymphomas, myeloproliferative neoplasms, multiple myeloma, and much more. This section features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in hematologic cancers.

Rituximab Biosimilar Succeeds in Phase III Follicular Lymphoma Trial

January 25th 2018

PF-05280586, a biosimilar for rituximab (Rituxan/MabThera), delivered positive top-line results in the phase III REFLECTIONS B3281006 follicular lymphoma trial.

Novel Agents Advance Field of AML

January 24th 2018

Gabriel Mannis, MD, discusses novel therapies shifting the treatment paradigm for patients with AML.

CHOP-RIT Superior for PFS Versus R-CHOP in High-Risk Follicular Lymphoma

January 23rd 2018

The CHOP-RIT regimen improved progression-free survival compared with R-CHOP alone in previously untreated patients with follicular lymphoma.

Dr. Smith on the Development of Active Therapeutic Combinations in Acute Myeloid Leukemia

January 23rd 2018

Catherine Smith, MD, assistant professor, Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, discusses developing active therapeutic combinations for the treatment of patients with acute myeloid leukemia

Emerging Therapies for Follicular Lymphoma

January 23rd 2018

FL: Updated Data for Immunomodulatory Approaches

January 23rd 2018

Immunomodulatory Therapy for FL: The R-Squared Regimen

January 23rd 2018

Further Considerations for Relapsed/Refractory FL

January 23rd 2018

Treatment Approaches to Relapsed Refractory FL

January 23rd 2018

Optimizing Frontline Therapy and Maintenance in FL

January 23rd 2018

Frontline Treatment Approaches to Follicular Lymphoma

January 23rd 2018

FL: Monitoring to Initiate Therapy and Gauge Response

January 23rd 2018

Risk Stratification and Outcomes in Follicular Lymphoma

January 23rd 2018

Diagnosis and Staging for Follicular Lymphoma

January 23rd 2018

Looking to the Future of Myeloma Care

January 23rd 2018

Improving Outcomes in Myeloma

January 23rd 2018

Immunotherapies in Myeloma

January 23rd 2018

Other Agents for Treating Myeloma

January 23rd 2018

Impact of MRD Assessment on Myeloma Treatment

January 23rd 2018

The Role of MRD Testing in Myeloma

January 23rd 2018